Kepos Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Kepos Capital’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-77,525	Closed	-$434K	–	431
2019 Q3	$434K	Buy	+77,525	New	+$924K	0.04%	210
2019 Q2	–	Sell	-7,500	Closed	-$155K	–	423
2019 Q1	$155K	Buy	+7,500	New	+$154K	0.01%	319

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kepos Capital's DMTK Position: Q4 2019 in Review

Kepos Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2019, closing a stake of 77,525 shares — an estimated $434K sold.

Kepos Capital first reported a position in DMTK in Q1 2019 and held it in 2 quarters. The position peaked at $434K in Q3 2019. 9 funds tracked by Wall St. Rank hold DMTK as of Q4 2019.

Kepos Capital reported no remaining DermTech, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Kepos Capital sold 77,525 DermTech, Inc. Common Stock shares in Q4 2019, an estimated $434K.
Kepos Capital first reported a position in DermTech, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
Kepos Capital's DermTech, Inc. Common Stock position peaked at $434K in Q3 2019.
9 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2019.

Based on Kepos Capital's 13F filing for Q4 2019, filed 13 Feb 2020.